Heart and vascular wall as targets for tissue converting enzyme inhibition.
D000803:Angiotensin I / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001158:Arteries / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects*; D001920:Bradykinin / Q000494:pharmacology; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology; D004727:Endothelium / Q000502:physiology; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D066298:In Vitro Techniques; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D017257:Ramipril; D051381:Rats
D000806:Angiotensin-Converting Enzyme Inhibitors; D001643:Bridged Bicyclo Compounds; D000804:Angiotensin II; D000803:Angiotensin I; D017257:Ramipril; D001920:Bradykinin